Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dror Michaelson

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
The Oncologist|May 1, 2019
Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?Xin Gao, David F McDermott, M Dror Michaelson
Clinical Genitourinary Cancer|March 3, 2012
Importance of fibroblast growth factor receptor in neovascularization and tumor escape from antiangiogenic therapyPhilip J Saylor, Bernard Escudier, M Dror Michaelson
Clinical Evidence|November 24, 2004
Prostate cancer (metastatic)M Dror Michaelson, Matthew R Smith, James A Talcott
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Long-term bisphosphonate treatment of bone metastases from renal cell carcinomaM Dror Michaelson, Daniel I Rosenthal, Matthew R Smith
Clinical Evidence|February 27, 2003
Prostate cancer: metastaticM Dror Michaelson, James A Talcott, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Contribution of androgen deprivation therapy to elevated osteoclast activity in men with metastatic prostate cancerM Dror Michaelson, Rose M Marujo, Matthew R Smith
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Transitional cell carcinoma of the upper uroepithelial tractM Dror Michaelson, Donald S Kaufman, William K Oh
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2006
Use of an arterial tourniquet to achieve complete radiofrequency ablation of a renal metastasisJustin Campbell, Daniel I Rosenthal, Kevin A Raskin, et al.
Cancer|June 29, 2006
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancerM Dror Michaelson, Donald S Kaufman, Philip Kantoff, et al.
Clinical Genitourinary Cancer|September 18, 2016
Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With SunitinibAvishay Sella, M Dror Michaelson, Ewa Matczak, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
The Oncologist|May 1, 2019
Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?Xin Gao, David F McDermott, M Dror Michaelson
Clinical Genitourinary Cancer|March 3, 2012
Importance of fibroblast growth factor receptor in neovascularization and tumor escape from antiangiogenic therapyPhilip J Saylor, Bernard Escudier, M Dror Michaelson
Clinical Evidence|November 24, 2004
Prostate cancer (metastatic)M Dror Michaelson, Matthew R Smith, James A Talcott
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2004
Long-term bisphosphonate treatment of bone metastases from renal cell carcinomaM Dror Michaelson, Daniel I Rosenthal, Matthew R Smith
Clinical Evidence|February 27, 2003
Prostate cancer: metastaticM Dror Michaelson, James A Talcott, Matthew R Smith
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Contribution of androgen deprivation therapy to elevated osteoclast activity in men with metastatic prostate cancerM Dror Michaelson, Rose M Marujo, Matthew R Smith
Clinical Advances in Hematology & Oncology : H&O|October 15, 2005
Transitional cell carcinoma of the upper uroepithelial tractM Dror Michaelson, Donald S Kaufman, William K Oh
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2006
Use of an arterial tourniquet to achieve complete radiofrequency ablation of a renal metastasisJustin Campbell, Daniel I Rosenthal, Kevin A Raskin, et al.
Cancer|June 29, 2006
Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancerM Dror Michaelson, Donald S Kaufman, Philip Kantoff, et al.
Clinical Genitourinary Cancer|September 18, 2016
Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With SunitinibAvishay Sella, M Dror Michaelson, Ewa Matczak, et al.
Pageof 12